Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

NCT05521997 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT05521997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05521997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
March 7, 2033
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cervical carcinoma, cancer of the cervix, cervical cancer, cervix cancer